-$0.22 Earnings Per Share Expected for Senesco Technologies Inc. (NYSE:ELOX) This Quarter

Wall Street brokerages expect Senesco Technologies Inc. (NYSE:ELOX) to announce ($0.22) earnings per share for the current quarter, according to Zacks Investment Research. Zero analysts have made estimates for Senesco Technologies’ earnings, with the highest EPS estimate coming in at ($0.19) and the lowest estimate coming in at ($0.25). Senesco Technologies reported earnings of ($0.40) per share during the same quarter last year, which would indicate a positive year over year growth rate of 45%. The firm is expected to announce its next quarterly earnings report before the market opens on Wednesday, August 5th.

According to Zacks, analysts expect that Senesco Technologies will report full-year earnings of ($1.05) per share for the current year, with EPS estimates ranging from ($1.16) to ($0.93). For the next year, analysts expect that the firm will report earnings of ($0.98) per share, with EPS estimates ranging from ($1.11) to ($0.84). Zacks’ earnings per share averages are a mean average based on a survey of sell-side analysts that cover Senesco Technologies.

Senesco Technologies (NYSE:ELOX) last announced its earnings results on Thursday, May 7th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.29) by ($0.06).

Shares of Senesco Technologies stock opened at $3.00 on Monday. The stock has a 50 day moving average price of $3.12 and a two-hundred day moving average price of $3.42. Senesco Technologies has a 12-month low of $1.44 and a 12-month high of $9.00.

About Senesco Technologies

Eloxx Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, focuses on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases. Its lead program is ELX-02, which is in Phase I clinical trial, which focuses on the treatment of cystic fibrosis and cystinosis patients with diagnosed nonsense mutations.

See Also: CD Ladder

Get a free copy of the Zacks research report on Senesco Technologies (ELOX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Senesco Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senesco Technologies and related companies with MarketBeat.com's FREE daily email newsletter.